Enveric Biosciences ENVB
NASDAQ ENVB
$1.43 +0.04 (+2.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Property, Plant & Equipment (Net) (2015 - 2026)

Enveric Biosciences (ENVB) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Enveric Biosciences 5.66 Mn -2.64 Mn - 81,929.00

Historic Data

Download Data
DateValue
Mar 31, 2026 119,927.00
Mar 31, 2026 119,927.00
Dec 31, 2025 159,234.00
Dec 31, 2025 159,234.00
Sep 30, 2025 196,521.00
Sep 30, 2025 196,521.00
Jun 30, 2025 241,082.00
Jun 30, 2025 241,082.00
Mar 31, 2025 267,279.00
Mar 31, 2025 267,279.00
Dec 31, 2024 305,777.00
Dec 31, 2024 305,777.00
Sep 30, 2024 367,689.00
Sep 30, 2024 367,689.00
Jun 30, 2024 405,114.00
Jun 30, 2024 405,114.00
Mar 31, 2024 452,228.00
Mar 31, 2024 452,228.00
Dec 31, 2023 507,377.00
Dec 31, 2023 507,377.00